Ranolazine
medication Under reviewA prescription anti-anginal medication used to treat chronic stable angina.
Research summary
Clinical trials demonstrate ranolazine improves exercise duration, delays angina onset, and reduces angina episodes in patients with chronic stable angina when used as monotherapy or add-on therapy. Evidence from randomized controlled trials supports its efficacy in enhancing functional capacity, though studies primarily involve patients with symptomatic angina rather than completely healthy individuals. Long-term safety data indicate good tolerability with low discontinuation rates due to adverse events.
Reported Benefits
No reports yet
Be the first to report this effect and help the community.
Add Ranolazine to your stack to report effects
Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective.
Thadani U, et al.
The usefulness of ranolazine for the treatment of refractory chronic stable angina pectoris as determined from a systematic review of randomized controlled trials.
Not specified
Monotherapy Assessment of Ranolazine In Stable Angina (MARISA) Trial
Chaitman BR, Pepine CJ, Parker JO, et al.
Effects of ranolazine on exercise tolerance and angina frequency in patients with severe chronic angina receiving maximally-tolerated background therapy: analysis from the Combination Assessment of Ranolazine In Stable Angina (CARISA) randomized trial.
Chaitman BR, Skettino SL, Parker JO, et al.
No reports yet
Be the first to report this effect and help the community.
Add Ranolazine to your stack to report effects
Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective.
Thadani U, et al.
MERLIN-TIMI 36 Trial: Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes
Morrow DA, Scirica BM, Karwatowska-Prokopczuk E, et al.
Monotherapy Assessment of Ranolazine In Stable Angina (MARISA) Trial
Chaitman BR, Pepine CJ, Parker JO, et al.
Effects of ranolazine on exercise tolerance and angina frequency in patients with severe chronic angina receiving maximally-tolerated background therapy: analysis from the Combination Assessment of Ranolazine In Stable Angina (CARISA) randomized trial.
Chaitman BR, Skettino SL, Parker JO, et al.
No reports yet
Be the first to report this effect and help the community.
Add Ranolazine to your stack to report effects
Effects of ranolazine on exercise tolerance and angina frequency in patients with severe chronic angina receiving maximally-tolerated background therapy: analysis from the Combination Assessment of Ranolazine In Stable Angina (CARISA) randomized trial.
Chaitman BR, Skettino SL, Parker JO, et al.
Monotherapy Assessment of Ranolazine In Stable Angina (MARISA) Trial
Chaitman BR, Pepine CJ, Parker JO, et al.
The usefulness of ranolazine for the treatment of refractory chronic stable angina pectoris as determined from a systematic review of randomized controlled trials.
Not specified
No side effects tracked yet
No side effects have been reported by studies or users for this habit yet.
Research (5 studies)
The usefulness of ranolazine for the treatment of refractory chronic stable angina pectoris as determined from a systematic review of randomized controlled trials.
Not specified
Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective.
Thadani U, et al.
MERLIN-TIMI 36 Trial: Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes
Morrow DA, Scirica BM, Karwatowska-Prokopczuk E, et al.
Effects of ranolazine on exercise tolerance and angina frequency in patients with severe chronic angina receiving maximally-tolerated background therapy: analysis from the Combination Assessment of Ranolazine In Stable Angina (CARISA) randomized trial.
Chaitman BR, Skettino SL, Parker JO, et al.
Monotherapy Assessment of Ranolazine In Stable Angina (MARISA) Trial
Chaitman BR, Pepine CJ, Parker JO, et al.
Community updates
No updates yet for this supplement.
Be the first to share your experience!